Stifel initiated coverage of Structure Therapeutics (GPCR) with a Buy rating and $50 price target Structure aims to expand the reach of metabolic treatments across the large, heterogeneous obesity ...

In a report released today, Stephen Soock from Stifel Nicolaus maintained a Buy rating on Vizsla Silver (VZLA – Research Report), with a price target of C$4.75. The company’s shares closed ...

We recently published a list of Top 10 AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Astera Labs, Inc. (NASDAQ:ALAB) stands against other AI stocks on Wall ...

Hasbro (NASDAQ:HAS – Free Report) had its target price trimmed by Stifel Nicolaus from $82.00 to $77.00 in a research report report published on Friday morning,Benzinga reports. The firm ...

Stifel has a Buy rating on Neumora, whose shares are down $8.69, or 82%, to $1.91 in pre-market trading.

Investing.com -- Stifel analysts downgraded Canoo from Buy to Hold in a note Tuesday, citing growing concerns about the company's liquidity risks. The downgrade comes after a series of ...

If you’re on the fence about investing in Stifel Financial Corp. or Morgan Stanley because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...